PET/CT in Patients with Breast Cancer Treated with Immunotherapy.

Vaz, Sofia C; Graff, Stephanie L; Ferreira, Arlindo R; Debiasi, Márcio; de Geus-Oei, Lioe-Fee

Vaz, Sofia C; Graff, Stephanie L; Ferreira, Arlindo R; Debiasi, Márcio; de Geus-Oei, Lioe-Fee.

Afiliación

Vaz SC; Nuclear Medicine-Radiopharmacology, Champalimaud Center for the Unkown, Champalimaud Foundation, 1400-038 Lisbon, Portugal.
Graff SL; Department of Radiology, Leiden University Medical Center, P.O. Box 9600-2300 RC Leiden, The Netherlands.
Ferreira AR; Division of Hematology/Oncology, Lifespan Cancer Institute, Providence, RI 02903, USA.
Debiasi M; Legorreta Cancer Center, The Warren Alpert Medical School, Brown University, Providence, RI 02903, USA.
de Geus-Oei LF; Católica Medical School, Universidade Católica Portuguesa, 2635-631 Lisbon, Portugal.

Cancers (Basel) ; 15(9)2023 May 05.

Article en En | MEDLINE | ID: mdl-37174086

Palabras clave

FDG; PET/TC; biomarkers; breast cancer; immune checkpoint inhibitors; immuno-PET; immunotherapy; mAb

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Portugal Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google